Dermira Культура компании

Mr. Thomas G. Wiggans, also known as Tom, co-founded Dermira, Inc. in August 2010 and has been its Chief Executive Officer since August 2010. Mr. Wiggans serves as an Advisor at Stiefel Laboratories. He has nearly 30 years of experience from the pharmaceutical and biotechnology industries. He served as the Chief Executive Officer of Peplin Inc. since August 15, 2008. He served as the Chief Executive Officer of Connetics Corporation from July 1994 to December 2006 and also served as its President from July 1994 to February 16, 2005. From February 1992 to April 1994, he served as the President and Chief Operating Officer at CytoTherapeutics Inc. From 1980 to February 1992, he served in various positions at Ares-Serono Group, including President of its U.S. Pharmaceutical Operations and Managing Director of Ares-Serono Group's U.K. Pharmaceutical Operations. From 1976 to 1980, Mr. Wiggans served various sales and marketing positions with Eli Lilly & Co. Prior to Connetics, he spent twelve years with the Ares-Serono Group in various management positions including President of its U.S. pharmaceutical operations and Managing Director of its U.K. pharmaceutical operations. Mr. Wiggans serves as the Chairman of Excaliard Pharmaceuticals, Inc. He has been the Chairman of Dermira, Inc. since April 2014. He serves as the Chairman of Biotechnology Institute, The. He served as the Chairman of Connetics Corporation from January 1, 2006 to December 2006. He served as the Chairman and Director of Peplin Inc. (alternate name, Peplin Limited) since October 2007. Mr. Wiggans serves as a Director of CellExSys, Inc. He has been an Independent Director of Annexon Biosciences, Inc. since March 9, 2017. He has been a Director of Dermira, Inc. since August 2010. He serves on the Board of Overseers of the Hoover Institution at Stanford University. He serves as a Trustee of the University of Kansas Endowment Association. He served as Director of Neothetics, Inc. (alternate name, Lithera, Inc.) from April 2011 to September 10, 2014 and Onyx Pharmaceuticals, Inc. from March 10, 2005 to 2013. He served as a Director of Sangamo Therapeutics, Inc. (alternate name, Sangamo Biosciences Inc.) from June 2008 to June 21, 2012 and Pernix Sleep, Inc. (alternate name, Somaxon Pharmaceuticals Inc.) from June 2008 to June 2012. He served as a Director of Victory Pharma, Inc. and Corthera Inc. Mr. Wiggans served as a Director of Biotechnology Innovation Organization (alternate name, Biotechnology Industry Organization). He served as a Director of Abgenix Inc. since April 2003. He served as a Director of Progen Pharmaceuticals, Inc. He served as a Director of Ipsen Biopharmaceuticals, Inc. (alternate name, Tercica Inc.) from April 19, 2005 to October 13, 2006, He served as a Director of Connetics Corporation from July 1994 to December 2006. Mr. Wiggans received a BS Degree in Pharmacy from the University of Kansas and an MBA Degree from Southern Methodist University.

Dr. Eugene Andrew Bauer, also known as Gene, M.D., Co-founded Dermira, Inc. in August 2010 and has been its Chief Medical Officer since October 2011. Dr. Bauer has been a Consultant of Medgenics, Inc. since June 30, 2012. He was a Founder and Consultant of Connetics Corporation since 1993. He has been a Lucy Becker Professor Emeritus of Dermatology at The Leland Stanford Junior University since 2002. He was the President, Chief Medical Officer and Executive Director at Peplin Inc. He served as a Vice President for Medical Affairs and Dean of the Stanford University School of Medicine from 1995 to 2001 and served as the Chairman of the Department of Dermatology at the Stanford University School of Medicine from 1988 to 1995. Dr. Bauer served as the Chief Medical Officer and President of Peplin, Inc. since August 18, 2008. Dr. Bauer served as the Chief Executive Officer and President at Neosil, Inc. from November 2004 to October 2008. He served as a Program Director of the Stanford University General Clinical Research Center. He has been the Chairman and Director at Dr. Tattoff, Inc. since August 2010. He served as the Chairman and Member of Scientific Advisory Board of WaferGen Bio-systems, Inc. since June 2007. He served as the Chairman of PROLOR Biotech, Inc. from 2005 to March 2008. He served as the Chairman of Cerecor, Inc. until January 10, 2012 and served as its Director until October 18, 2017. He served as a Non Executive Chairman of Medgenics, Inc. from July 2005 to June 30, 2012. He served as the Chairman of Vyteris, Inc. He served as an Executive Chairman of Aevi Genomic Medicine, Inc. from October 18, 2010 to June 30, 2012 and has been its Director since March 2001. He serves as a Director of BayBio, Neosil, Inc. and Kadmon Holdings, Inc. since 2010. He serves as a Director of First Wave Technologies, Inc. He has been a Director of Dermira, Inc. since August 2010. Dr. Bauer served as a Member of Strategic Advisory Board at Medgenics, Inc. He served as an Executive Director of Peplin, Inc. since June 24, 2006. He served as a Director of PROLOR Biotech, Inc. until March 2008. He served as a Director of Protalex Inc. from February 15, 2005 to November 2009 and Connetics Corporation from 1996 to October 2005. He served as a Member of Scientific and Medical Advisory Board at Medgenics, Inc. He served as a Director of Medisync Bioservices Inc. He served as an Independent Director of Echo Healthcare Acquisition Corp. He served as a Director Emeritus of Connetics Corporation since October 2005. He served as a Director of Patient Safety Technologies, Inc. from January 26, 2010 to June 2010. He served as a Director of Arbor Vita Corporation, Bay Area Bioscience Association and Pet DRx Corporation. Dr. Bauer was a U.S. National Institute of Health (NIH)-funded investigator for 25 years and served on review groups for the NIH. Dr. Bauer was elected to several societies including the Institute of Medicine of the National Academy of Sciences. Dr. Bauer received a B.S. in Medicine an M.D from Northwestern University.

Mr. Christopher M. Griffith, also known as Chris, Co-founded Dermira Inc. Mr. Griffith has been Senior Vice President of Corporate Development and Strategy at Dermira, Inc. since January 2017. and served as the Vice President of Corporate Development & Strategy since August 2011. Mr. Griffith served as an Analyst at Bay City Capital LLC. He performed company research and developed industry studies and financial analyses for BCC's investments and financial advisory assignments. He worked at Gilead Sciences Inc. He served as Marketing Associate at EXP.com, Inc. where he developed, implemented and evaluated marketing campaigns and conducted market research. He served as a Director at Dermira Inc. He received his MS and BS degrees in Biological Sciences from Stanford University.

Joseph Suttner serves as the Vice President Clinical Operations of Dermira, Inc.. Joseph started at Dermira, Inc. in Feb of 2017. Joseph currently resides in the San Francisco Bay Area.

Ray Bassi serves as the Vice President of Sales of Dermira, Inc.. Ray started at Dermira, Inc. in Jun of 2018. Ray currently resides in the San Francisco Bay Area.

Ryan Patterson serves as the Vice President, Marketing of Dermira, Inc.. Ryan started at Dermira, Inc. in Jul of 2017. Ryan currently resides in the San Francisco Bay Area.

Nick Williams serves as the Vice President Finance of Dermira, Inc.. Nick started at Dermira, Inc. in January of 2019. Nick currently resides in the San Francisco Bay Area.

Jenny Stevens serves as the Senior Director, Clinical and Biologics Quality of Dermira, Inc.. Jenny started at Dermira, Inc. in April of 2018. Jenny currently resides in the San Francisco Bay Area.